{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:27:39Z","timestamp":1790803659856,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ebiom.2026.106383","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T09:29:38Z","timestamp":1784021378000},"page":"106383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Metabolomic signatures for diagnosis and clinical severity in Parkinson's disease"],"prefix":"10.1016","volume":"130","author":[{"given":"Yige","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqin","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiurong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taole","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqiong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beisha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10423","key":"10.1016\/j.ebiom.2026.106383_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson's disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2026.106383_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021","volume":"388","author":"Su","year":"2025","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106383_bib3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","article-title":"Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis","volume":"86","author":"Rizzo","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106383_bib4","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/mds.27362","article-title":"Validation of the MDS clinical diagnostic criteria for Parkinson's disease","volume":"33","author":"Postuma","year":"2018","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106383_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol"},{"issue":"10291","key":"10.1016\/j.ebiom.2026.106383_bib6","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106383_bib7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib8","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","article-title":"Small molecule metabolites: discovery of biomarkers and therapeutic targets","volume":"8","author":"Qiu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ebiom.2026.106383_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fnagi.2018.00051","article-title":"Promising metabolite profiles in the plasma and CSF of early clinical Parkinson's disease","volume":"10","author":"Stoessel","year":"2018","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106383_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10100389","article-title":"Circulating metabolites as potential biomarkers for neurological disorders-metabolites in neurological disorders","volume":"10","author":"Donatti","year":"2020","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-018-0304-2","article-title":"Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease","volume":"14","author":"Shao","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106383_bib12","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/mds.27173","article-title":"Profiling novel metabolic biomarkers for Parkinson's disease using in-depth metabolomic analysis","volume":"32","author":"Han","year":"2017","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106383_bib13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ana.25516","article-title":"A metabolic profile of polyamines in Parkinson disease: a promising biomarker","volume":"86","author":"Saiki","year":"2019","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13024-021-00425-8","article-title":"Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry","volume":"16","author":"Shao","year":"2021","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41531-021-00239-x","article-title":"A six-metabolite panel as potential blood-based biomarkers for Parkinson's disease","volume":"7","author":"Klatt","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41531-024-00713-2","article-title":"Metabolic profiling reveals circulating biomarkers associated with incident and prevalent Parkinson's disease","volume":"10","author":"Hu","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41531-024-00741-y","article-title":"Prediction of motor and non-motor Parkinson's disease symptoms using serum lipidomics and machine learning: a 2-year study","volume":"10","author":"Galper","year":"2024","journal-title":"NPJ Parkinsons Dis"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106383_bib18","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106383_bib19","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mds.29410","article-title":"Levodopa dose equivalency in Parkinson's disease: updated systematic review and proposals","volume":"38","author":"Jost","year":"2023","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib20","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2115753118","article-title":"Locust density shapes energy metabolism and oxidative stress resulting in divergence of flight traits","volume":"119","author":"Du","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Database issue","key":"10.1016\/j.ebiom.2026.106383_bib21","doi-asserted-by":"crossref","first-page":"D527","DOI":"10.1093\/nar\/gkl838","article-title":"LMSD: LIPID MAPS structure database","volume":"35","author":"Sud","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.ebiom.2026.106383_bib22","doi-asserted-by":"crossref","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","article-title":"HMDB 5.0: the human metabolome database for 2022","volume":"50","author":"Wishart","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106383_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","article-title":"Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI)","volume":"3","author":"Sumner","year":"2007","journal-title":"Metabolomics"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106383_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11306-016-1026-5","article-title":"Normalization and integration of large-scale metabolomics data using support vector regression","volume":"12","author":"Shen","year":"2016","journal-title":"Metabolomics"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106383_bib26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1021\/ac051495j","article-title":"Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation","volume":"78","author":"Bijlsma","year":"2006","journal-title":"Anal Chem"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106383_bib27","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nprot.2011.335","article-title":"Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry","volume":"6","author":"Dunn","year":"2011","journal-title":"Nat Protoc"},{"issue":"W1","key":"10.1016\/j.ebiom.2026.106383_bib28","doi-asserted-by":"crossref","first-page":"W398","DOI":"10.1093\/nar\/gkae253","article-title":"MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation","volume":"52","author":"Pang","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nm.4451","article-title":"An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury","volume":"24","author":"Zhang","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41531-021-00216-4","article-title":"Prognostic biomarkers of Parkinson's disease in the Spanish EPIC cohort: a multiplatform metabolomics approach","volume":"7","author":"Gonzalez-Riano","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106383_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/jms.4781","article-title":"Targeted fatty acid metabolomics to discover Parkinson's disease associated metabolic alteration","volume":"56","author":"Zhang","year":"2021","journal-title":"J Mass Spectrom"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106383_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13090990","article-title":"Serum-based lipid panels for diagnosis of idiopathic Parkinson's disease","volume":"13","author":"Dahabiyeh","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.ebiom.2026.106383_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106788","article-title":"Plasma oxylipin profiles reflect Parkinson's disease stage","volume":"171","author":"Chistyakov","year":"2024","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106383_bib34","doi-asserted-by":"crossref","first-page":"716","DOI":"10.18632\/aging.100361","article-title":"Polyamines in aging and disease","volume":"3","author":"Minois","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ebiom.2026.106383_bib35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev-biochem-071322-021330","article-title":"Polyamines in Parkinson's disease: balancing between neurotoxicity and neuroprotection","volume":"92","author":"Vrijsen","year":"2023","journal-title":"Annu Rev Biochem"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2026.106383_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3940(01)01776-1","article-title":"Polyamines in the basal ganglia of human brain. Influence of aging and degenerative movement disorders","volume":"304","author":"Vivo","year":"2001","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106383_bib37","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1006\/exnr.2002.7952","article-title":"Increased red blood cell polyamines in ALS and Parkinson's disease","volume":"177","author":"Gomes-Trolin","year":"2002","journal-title":"Exp Neurol"},{"issue":"19\u201320","key":"10.1016\/j.ebiom.2026.106383_bib38","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.cca.2010.05.034","article-title":"Polyamine patterns in the cerebrospinal fluid of patients with Parkinson's disease and multiple system atrophy","volume":"411","author":"Paik","year":"2010","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ebiom.2026.106383_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111499","article-title":"Progresses in both basic research and clinical trials of NAD+ in Parkinson's disease","volume":"197","author":"Perez","year":"2021","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106383_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tem.2018.11.003","article-title":"Sphingolipids in the pathogenesis of Parkinson's disease and parkinsonism","volume":"30","author":"Lin","year":"2019","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-020-00408-1","article-title":"Glycosphingolipids and neuroinflammation in Parkinson's disease","volume":"15","author":"Belarbi","year":"2020","journal-title":"Mol Neurodegener"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106383_bib42","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1210\/endrev\/bnad019","article-title":"Nicotinamide adenine dinucleotide in aging biology: potential applications and many unknowns","volume":"44","author":"Bhasin","year":"2023","journal-title":"Endocr Rev"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106383_bib43","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1093\/brain\/awac176","article-title":"Lipid pathway dysfunction is prevalent in patients with Parkinson's disease","volume":"145","author":"Galper","year":"2022","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106383_bib44","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awx285","article-title":"Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease","volume":"140","author":"Robak","year":"2017","journal-title":"Brain"},{"issue":"14","key":"10.1016\/j.ebiom.2026.106383_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147630","article-title":"Parkinson's disease-related genes and lipid alteration","volume":"22","author":"Fais","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106383_bib46","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/brain\/awac413","article-title":"GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's disease","volume":"146","author":"Senkevich","year":"2023","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106383_bib47","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jnc.14104","article-title":"Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia","volume":"142","author":"Havelund","year":"2017","journal-title":"J Neurochem"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106383_bib48","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/mds.28052","article-title":"Microbiota composition and metabolism are associated with gut function in Parkinson's disease","volume":"35","author":"Cirstea","year":"2020","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13024-023-00694-5","article-title":"Untargeted serum metabolomics reveals novel metabolite associations and disruptions in amino acid and lipid metabolism in Parkinson's disease","volume":"18","author":"Paul","year":"2023","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41531-023-00612-y","article-title":"Plasma metabolites of aromatic amino acids associate with clinical severity and gut microbiota of Parkinson's disease","volume":"9","author":"Chen","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106383_bib51","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41582-022-00681-2","article-title":"The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic","volume":"18","author":"Tan","year":"2022","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib52","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1038\/s41467-022-34667-x","article-title":"Metagenomics of Parkinson's disease implicates the gut microbiome in multiple disease mechanisms","volume":"13","author":"Wallen","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106383_bib53","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/mds.29959","article-title":"Metagenomic analysis reveals large-scale disruptions of the gut microbiome in Parkinson's disease","volume":"39","author":"Metcalfe-Roach","year":"2024","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7010019","article-title":"Microbial fermentation of dietary protein: an important factor in Diet(-)Microbe(-)Host interaction","volume":"7","author":"Diether","year":"2019","journal-title":"Microorganisms"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106383_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2026.106383_bib56","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.freeradbiomed.2015.04.004","article-title":"The deleterious metabolic and genotoxic effects of the bacterial metabolite p-cresol on colonic epithelial cells","volume":"85","author":"Andriamihaja","year":"2015","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106383_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2016.93","article-title":"Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut","volume":"1","author":"Roager","year":"2016","journal-title":"Nat Microbiol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106383_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13060857","article-title":"Effects of p-cresol on oxidative stress, glutathione depletion, and necrosis in HepaRG cells: comparisons to other uremic toxins and the role of p-Cresol glucuronide formation","volume":"13","author":"Zhu","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106383_bib59","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/brain\/awab320","article-title":"Bacterial neurotoxic metabolites in multiple sclerosis cerebrospinal fluid and plasma","volume":"145","author":"Ntranos","year":"2022","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib60","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2022.2073175","article-title":"A host-gut microbial amino acid co-metabolite, p-cresol glucuronide, promotes blood-brain barrier integrity in vivo","volume":"11","author":"Stachulski","year":"2023","journal-title":"Tissue Barriers"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106383_bib61","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2431651","article-title":"Cerebrovascular damage caused by the gut microbe\/host co-metabolite p-cresol sulfate is prevented by blockade of the EGF receptor","volume":"16","author":"Shah","year":"2024","journal-title":"Gut Microbes"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106383_bib62","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s43587-024-00795-w","article-title":"Gut microbial-derived phenylacetylglutamine accelerates host cellular senescence","volume":"5","author":"Yang","year":"2025","journal-title":"Nat Aging"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:16:43Z","timestamp":1786522603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426002677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":62,"alternative-id":["S2352396426002677"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106383","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomic signatures for diagnosis and clinical severity in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106383"}}